{"id":"NCT03610646","sponsor":"Mylan Pharmaceuticals Inc","briefTitle":"Comparative Study to Evaluate the Efficacy and Safety of MYL-1701P and Eylea® in Subjects With Diabetic Macular Edema (DME)","officialTitle":"A Multi Center, Randomized, Double-Masked, Active-Controlled, Comparative Clinical Study to Evaluate the Efficacy and Safety of MYL-1701P and Eylea® in Subjects With Diabetic Macular Edema (DME)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2018-08-23","primaryCompletion":"2020-11-10","completion":"2021-09-10","firstPosted":"2018-08-01","resultsPosted":"2023-03-07","lastUpdate":"2023-03-07"},"enrollment":355,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"TRIPLE","primaryPurpose":"TREATMENT"},"conditions":["Diabetic Macular Edema"],"interventions":[{"type":"DRUG","name":"MYL-1701P","otherNames":[]},{"type":"DRUG","name":"Eylea","otherNames":[]}],"arms":[{"label":"MYL-1701P","type":"EXPERIMENTAL"},{"label":"Eylea","type":"ACTIVE_COMPARATOR"}],"summary":"Three hundred and twenty-four (324) eligible adult subjects with diabetes mellitus with central DME involvement to be randomized 1:1 to intravitreal treatment with MYL-1701P or Eylea®.\n\nThe primary endpoint is mean change from baseline in Best Corrected Visual Acuity (BCVA) as assessed by Early Treatment Diabetic Retinopathy Study (ETDRS) letters. Pharmacokinetics (PK) and immunogenicity to be evaluated in the subjects participating in the study.","primaryOutcome":{"measure":"Mean Change From Baseline in Best Corrected Visual Acuity (BCVA) at Week 8","timeFrame":"Baseline and 8 weeks","effectByArm":[{"arm":"MYL-1701P","deltaMin":6.6,"sd":0.548},{"arm":"Eylea","deltaMin":6.56,"sd":0.548}],"pValues":[{"comp":"OG000 vs OG001","p":null}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":73,"countries":["United States","Czechia","Germany","Hungary","India","Japan","Latvia","Poland","Russia"]},"refs":{"pmids":["39264599"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":31,"n":178},"commonTop":["Hypertension","Cataract","Nasopharyngitis","Diabetic retinal oedema","Diabetes mellitus"]}}